Hints and tips:
Related Special Reports
...“Illumina doesn’t want a fast process in court, they are playing delay tactics,” alleged a person with direct knowledge of the EU’s position....
...According to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based lobby group, the US attracted a third more R&D investment than Europe in 2010....
...But is that a systemic risk? I’d say probably not. One good read A carbon tax by other means....
...“I think something that I should have explained better at earnings was that almost all of the increase in investment in R&D is in D. Because that’s where the action is for us....
...The active ingredient is used in La Roche Posay’s Lipikar Eczema Med cream....
...EU regulators will order US biotech Illumina to sell cancer test developer Grail after it bought the $8bn company without the approval of Brussels, according to three people with direct knowledge of the...
...But funding the R&D necessary to make this a reality means the company is going to need to raise more money first....
...So it’d be really interesting to see whether that changes the game for some health systems. Michela Tindera Mmm....
...US drugmaker Eli Lilly is riding a wave of investor optimism and media hype about new treatments for two of the biggest public health problems: obesity and Alzheimer’s....
...Moran said that competition for life sciences investment from the US was becoming more intense following a US push to “reshore” manufacturing, a key plank of President Joe Biden’s economic programme....
...I'm a founder of 3P Innovation. We make custom automation mainly for the pharmaceutical industries. We've lost about half our growth as a direct result of Brexit....
...In the US there is no disclosure requirement for D&O [directors and officers] insurance,” he said....
...“This value destruction is a direct result of a series of ill-advised (and frankly inexplicable) actions taken by the board of directors of our company in connection with the acquisition of Grail....
...Kate We were just afraid she was going to hurt herself or hurt us. She was murderous as well as, um, suicidal. She’d pick up a knife....
...I was just having a conversation about a week ago with a friend who is telling me that she, like, has had some very ambiguous health problems....
...Meanwhile, our share of the global pharmaceutical R&D market is declining....
...pharmaceutical companies....
...About 100,000 Americans live with sickle cell disease in the US, compared with only around 6,000 people with haemophilia B....
...Born in Ekaterinburg, Russia, Malievskaia trained as a doctor in St Petersburg before moving to the US in 1991, where she received an MSc in public health at New York University....
...Paul Hastings O: 6; L: 7; I: 7; Total: 20The firm advised South Korean pharmaceutical company SD Biosensor and South Korean private equity fund SJL Partners on the acquisition of US-listed pharmaceutical...
...GSK and Pfizer are the frontrunners in a race for an RSV vaccine, kicked off again by a breakthrough by Jason McLellan and Barney Graham, scientists at the US National Institutes of Health who showed how...
...lack of humility about this is a situation that we a) don’t understand very well, and b) hadn’t planned for particularly well....
...Finished in 2001, its $69mn construction was partly paid for by the sale of pharmaceutical stocks donated to Opus Dei by a private individual....
...Airfinity, a health data analytics group, forecasts sales of Covid vaccines falling by about a fifth to $47bn next year....
...Arizona/Utah border must be one of the most bizarre holiday experiences available in the US....
International Edition